Results 91 to 100 of about 350,037 (355)

Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial. [PDF]

open access: yes, 2017
More efficacious treatment regimens are needed for tuberculosis, however, drug development is impeded by a lack of reliable biomarkers of disease severity and of treatment effect. We conducted a directed screen of host biomarkers in participants enrolled
Barbero, S   +14 more
core   +2 more sources

Mortality from cancer and non‐cancer diseases in the Lithuanian cohort of Chernobyl cleanup workers (2001–2020)

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Following the Chernobyl disaster, workers were recruited from formerly Soviet‐occupied areas, including Lithuania, to participate in clean‐up efforts. Radiation exposure incurred by workers during these efforts offers a unique opportunity for the study of long‐term health effects.
Rita Steponaviciene   +3 more
wiley   +1 more source

Review of multidrug-resistant and extensively drug-resistant TB: global perspectives with a focus on sub-Saharan Africa [PDF]

open access: yes, 2010
Tuberculosis (TB) remains a global emergency and is responsible for 1.7 million deaths annually. Widespread global misuse of isoniazid and rifampicin over three decades has resulted in emergence of the ominous spread of multidrug-resistant TB (MDR-TB ...
Abdool Karim   +70 more
core   +1 more source

Immunometabolic Features and Key Biomarkers in Lung Cancer Complicated by Pulmonary Tuberculosis: Insights From Transcriptome and Clinical Cohort Analysis

open access: yesiMetaMed, EarlyView.
Integrative analysis of LC‐PTB patients pinpoints six biomarkers (ANK2, EPB42, CA1, HBB, HBD, MYL4) that reshape the immune microenvironment, offering new targets for diagnosis and treatment of lung cancer complicated by tuberculosis. ABSTRACT Coexisting lung cancer and pulmonary tuberculosis (LC‐PTB) is clinically challenging in diagnosis and ...
Ling Yang   +10 more
wiley   +1 more source

Diagnostic performance of adenosine deaminase activity in pleural fluid in tuberculous pleural effusion and relevant factors: a single-center experience with 1,491 consecutive patients

open access: yesBMC Pulmonary Medicine
Objective Adenosine deaminase (ADA) is a widely-used diagnostic test for tuberculous pleural effusion (TPE), but its accuracy, optimal diagnostic threshold and relevant factors are controversial or unclear. We aimed to reassess these diagnostic variables
Chi Yang   +6 more
doaj   +1 more source

Nanopore-targeted sequencing: A new and effective technique for the diagnosis of non-tuberculous mycobacteria pulmonary disease

open access: yesInternational Journal of Medical Microbiology
Non-tuberculous mycobacteria pulmonary disease (NTM-PD) has become a significant public health issue threatening human health in recent years. Traditional mycobacterial culture is complex, time-consuming, and unable to identify NTM at the species level ...
Li-ping Cheng   +9 more
doaj   +1 more source

Pulmonary Tuberculosis [PDF]

open access: yesPulmonary Medicine, 2013
Anete Trajman   +3 more
openaire   +3 more sources

iMeta Conference 2025: Creating high‐impact international journals

open access: yesiMeta, EarlyView.
The iMeta Conference 2025, part of the iMeta Conference series, themed “Creating High‐Impact International Journals,” held at the Huangjiahu Campus of Hubei University of Chinese Medicine from August 23rd to 25th, 2025, and focused on frontier topics such as microbiology, medicine, traditional Chinese medicine, botany, and research career development ...
Zhihao Zhu   +229 more
wiley   +1 more source

Polymorphism in the EREG gene confers susceptibility to tuberculosis

open access: yesBMC Medical Genetics, 2019
Background Host genetic factors affect the immune response to Mycobacterium tuberculosis (Mtb) infection as well as the progression of the disease. Epiregulin (EREG) belongs to the epidermal growth factor (EGF) family, which binds to the epidermal growth
Wen Cao   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy